Veterinary Medicines

Albendazole 300/Anafasis, 300mg/tab δισκία για πρόβατα

Authorised
  • Albendazole
Download as PDF

Product identification

Medicine name:
Albendazole 300/Anafasis, 300mg/tab δισκία για πρόβατα
Active substance:
  • Albendazole
Target species:
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Albendazole
    300.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        10
        day
      • Milk
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Uplab Pharmaceutical Company Ltd.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 95613/20-10-2021/K-0160301
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 7/11/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 7/11/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."